Skip to main content
ARAY
NASDAQ Industrial Applications And Services

Accuray Seeks Stockholder Approval for $55M Recapitalization, Reverse Split, and Massive Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.28
Mkt Cap
$33.441M
52W Low
$0.22
52W High
$2.1
52W Position info
27% above low
Off High info
87% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

ARAY sits 27% above its 52-week low of $0.22 on light trading volume (0.3× avg).

Summary

Accuray seeks stockholder approval for a $55M recapitalization, reverse stock split, and authorized share increase to avoid default and regain Nasdaq compliance.


Key Events · Financing and Capital Events · ARAY

  • Recapitalization Terms

    Accuray will issue 55,000 shares of Series A Preferred Stock for $55 million: $15 million in cash and $40 million in debt conversion. The preferred stock converts into 110 million common shares at $0.50 per share.

  • Massive Dilution

    Conversion of preferred stock and exercise of 15.3 million warrants at $0.01 per share would increase outstanding shares from approximately 119.4 million to over 244 million, diluting existing holders by more than 100%.

  • Reverse Stock Split

    A reverse split of 1-for-15 to 1-for-40 is proposed to raise the stock price above $1.00 and regain Nasdaq compliance. The exact ratio will be determined by the Board.

  • Authorized Share Increase

    Authorized common shares would increase from 200 million to 400 million to accommodate the conversion of preferred stock.


Analysis · ARAY · Industrial Applications And Services

Accuray is asking stockholders to approve a $55 million recapitalization that will convert $40 million of debt into preferred stock and raise $15 million in cash. The deal includes a reverse stock split of 1-for-15 to 1-for-40 to regain Nasdaq compliance, and an increase in authorized shares from 200 million to 400 million. If approved, the preferred stock converts into 110 million common shares at $0.50 per share, and warrants for 15.3 million shares at $0.01 per share are issued. This will cause substantial dilution to existing holders, but the alternative is a $15 million fee and continued debt burden. The special meeting is set for October 6, 2026.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 41.9% of the 327 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.46%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ARAY was trading at $0.28 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $33.4M. The 52-week trading range was $0.22 to $2.10. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ARAY - Latest Insights

ARAY
Sep 11, 2026, 9:55 AM EDT
Source: MFN by Modular Finance
Importance Score:
7
Price at Filing: $0.2558
Real-time Price: $0.261 info
Change: +$0.0052 (+2%) info
Market Cap: $32.261M info
ARAY
Aug 27, 2026, 4:02 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.2621
Real-time Price: $0.261 info
Change: -$0.0011 (-0.42%) info
Market Cap: $32.261M info
ARAY
Aug 24, 2026, 4:02 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.2716
Real-time Price: $0.261 info
Change: -$0.0106 (-4%) info
Market Cap: $32.261M info
ARAY
Aug 19, 2026, 4:05 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $0.3001
Real-time Price: $0.261 info
Change: -$0.0391 (-13%) info
Market Cap: $32.261M info
ARAY
Aug 19, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3157
Real-time Price: $0.261 info
Change: -$0.0547 (-17%) info
Market Cap: $32.261M info